Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients ㉥ 75 years: results of a real-world cohort including 456 patients

DSpace Repository

Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients ㉥ 75 years: results of a real-world cohort including 456 patients

Author: Gawaz, A.; Wolff, I.; Nanz, L.; Flatz, L.; Forschner, A.
Tübinger Autor(en):
Gawaz, Andrea
Wolff, Ines
Nanz, Lena
Flatz, Lukas
Forschner, Andrea Lydia
Published in: Cancer Immunology Immunotherapy (2024), Bd. 73 (9), Article 185
Verlagsangabe: New York : Springer
Language: English
Full text: http://dx.doi.org/10.1007/s00262-024-03750-1
ISSN: 0340-7004
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)